PPARα Mediates Transcriptional Upregulation of Novel Organic Cation Transporters-2 and -3 and Enzymes Involved in Hepatic Carnitine Synthesis
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
We tested the hypothesis that transcription of novel organic cation transporters (OCTNs) is directly regulated by peroxisome proliferator–activated receptor (PPAR)-α. Therefore, wild-type mice and mice deficient in PPARα (PPARα −/− ) were treated with the PPARα agonist WY 14,643. Wild-type mice treated with WY 14,643 had a greater abundance of OCTN2 mRNA in their liver, muscle, kidney, and small intestine and a greater abundance of OCTN3 mRNA in kidney and small intestine than did untreated wild-type mice ( P < 0.05). Moreover, wild-type mice treated with WY 14,643 had greater mRNA abundances of enzymes involved in hepatic carnitine synthesis (4-N-trimethylaminobutyraldehyde dehydrogenase, γ-butyrobetaine dioxygenase) and increased carnitine concentrations in liver and muscle than did untreated wild-type mice ( P < 0.05). Untreated PPARα −/− mice had a lower abundance of OCTN2 mRNA in liver, kidney, and small intestine and lower carnitine concentrations in plasma, liver, and kidney than did untreated wild-type mice ( P < 0.05). In PPARα −/− mice, treatment with WY 14,643 did not influence mRNA abundance of OCTN2 and OCTN3 and carnitine concentrations in all tissues analyzed. The abundance of OCTN1 mRNA in all the tissues analyzed was not changed by treatment with WY 14,643 in wild-type or PPARα −/− mice. In conclusion, this study shows that transcriptional upregulation of OCTN2 and OCTN3 in tissues and of enzymes involved in hepatic carnitine biosynthesis are mediated by PPARα. It also shows that PPARα mediates changes of whole-body carnitine homeostasis in mice by upregulation of carnitine transporters and enzymes involved in carnitine synthesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Consistent with these reports, short term high fat feeding (4 days), which activates the PPAR network, increases systemic carnitine levels (34,37).”
From Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control (2009) · cites this paper as [34]
In the citing paper
“Conversely, compounds belonging to the fibrate class of hypolipidemic drugs raise systemic carnitine levels, in parallel with increased hepatic expression of the carnitine biosynthetic machinery (34,35).”
From Carnitine insufficiency caused by aging and overnutrition compromises mitochondrial performance and metabolic control (2009) · cites this paper as [34]
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610 · cited 1×
“Calculation of relative mRNA abundance was made by using the DDCt method as previously described (30).”
MethodThe Mitochondrial Carnitine Palmitoyltransferase System — From Concept to Molecular Analysis
McGarry, J. D., & Brown, N. F. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00001.x · Cited by 1,616
Schoonjans, K., Staels, B., & Auwerx, J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42003-6 · Cited by 1,216
Tugwood, J. D., Issemann, I., Anderson, R. G., Bundell, K. R., McPheat, W. L., & Green, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05072.x · Cited by 895 · cited 1×
“To demonstrate PPARa activation, we determined the mRNA abundance of ACO, a gene that possesses a PPAR response element (32).”
BackgroundCarnitine biosynthesis in mammals
Vaz, F. M., & Wanders, R. J. A. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610417 · Cited by 764 · cited 2×
“Carnitine biosynthesis involves a complex series of reactions (6).”
BackgroundTamai, I., Ohashi, R., Nezu, J.-I., Yabuuchi, H., Oku, A., Shimane, M., Sai, Y., & Tsuji, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20378 · Cited by 697
The SLC22 drug transporter family
Koepsell, H., & Endou, H. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1089-9 · Cited by 525
Rat PPARs: Quantitative Analysis in Adult Rat Tissues and Regulation in Fasting and Refeeding
Escher, P., Braissant, O., Basu-Modak, S., Michalik, L., Wahli, W., & Desvergne, B. (2001) · Endocrinology · doi:10.1210/endo.142.10.8458 · Cited by 472
Cloning and characterization of a novel human pH‐dependent organic cation transporter, OCTN1
Tamai, I., Yabuuchi, H., Nezu, J.-I., Sai, Y., Oku, A., Shimane, M., & Tsuji, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01441-5 · Cited by 458
Carnitine: a nutritional, biosynthetic, and functional perspective
STEIBER, A. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.06.006 · Cited by 446
Kinetics, Pharmacokinetics, and Regulation of l‐Carnitine and Acetyl‐l‐carnitine Metabolism
REBOUCHE, C. J. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1320.003 · Cited by 425 · cited 1×
“Therefore, the availability of the carnitine precursors TML and BB is considered to be rate-limiting for carnitine biosynthesis (36).”
BackgroundCARNITINE METABOLISM AND ITS REGULATION IN MICROORGANISMS AND MAMMALS
Rebouche, C. J., & Seim, H. (1998) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.18.1.39 · Cited by 362 · cited 1×
“Carnitine is derived from dietary sources and endogenous biosynthesis (4, 5).”
BackgroundWu, X., Huang, W., Prasad, P. D., Seth, P., Rajan, D. P., Leibach, F. H., Chen, J., Conway, S. J., & Ganapathy, V. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35056-6 · Cited by 330 · cited 1×
“OCTN1 and OCTN2 are expressed in several tissues such as kidney, intestine, skeletal muscle, heart, liver, and brain (12, 15, 16).”
BackgroundMolecular and Functional Characterization of Organic Cation/Carnitine Transporter Family in Mice
Tamai, I., Ohashi, R., Nezu, J.-I., Sai, Y., Kobayashi, D., Oku, A., Shimane, M., & Tsuji, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005340200 · Cited by 292 · cited 5×
“In contrast, OCTN3 is expressed exclusively in testes, kidney, and intestine (12, 17).”
BackgroundInfluentialOhashi, R., Tamai, I., Yabuuchi, H., Nezu, J.-I., Oku, A., Sai, Y., Shimane, M., & Tsuji, A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35167-5 · Cited by 273 · cited 4×
“Lohninger A, Pittner G, Pittner F. L-carnitine: new aspects of a known compound—a brief survey.”
BackgroundInfluentialPeroxisome Proliferator-Activated Receptors, Coactivators, and Downstream Targets
Qi, C., Zhu, Y., & Reddy, J. K. (2000) · Cell Biochemistry and Biophysics · doi:10.1385/cbb:32:1-3:187 · Cited by 216 · cited 1×
“Similarly, hepatomegaly indicative of peroxisome proliferation (34) was observed in wildFigure 3.”
BackgroundOhashi, R., Tamai, I., Nezu, J.-I., Nikaido, H., Hashimoto, N., Oku, A., Sai, Y., Shimane, M., & Tsuji, A. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12847-7 · Cited by 185
Tissue Distribution and Renal Developmental Changes in Rat Organic Cation Transporter mRNA levels
Slitt, A. L., Cherrington, N. J., Hartley, D. P., Leazer, T. M., & Klaassen, C. D. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.2.212 · Cited by 169 · cited 1×
“OCTN1 and OCTN2 are expressed in several tissues such as kidney, intestine, skeletal muscle, heart, liver, and brain (12, 15, 16).”
BackgroundPivalate-Generating Prodrugs and Carnitine Homeostasis in Man
Brass, E. P. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.589 · Cited by 147
Carnitine transport: Pathophysiology and metabolism of known molecular defects
Tein, I. (2003) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1024481016187 · Cited by 140 · cited 2×
“The fact that inborn or acquired defects of OCTNs lead to primary or secondary systemic carnitine deficiency demonstrates their essential role in carnitine homeostasis (9).”
BackgroundSenekeo‐Effenberger, K., Chen, S., Brace‐Sinnokrak, E., Bonzo, J. A., Yueh, M., Argikar, U. A., Kaeding, J., Trottier, J., Remmel, R. P., Ritter, J. K., et al. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.013243 · Cited by 135 · cited 1×
“WY 14,643 was dissolved in DMSO and sunflower oil (50:50, v/v) at a final concentration of 8 mg/ml as described (26).”
MethodCarnitine Transport by Organic Cation Transporters and Systemic Carnitine Deficiency
Lahjouji, K., Mitchell, G. A., & Qureshi, I. A. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3207 · Cited by 133 · cited 1×
“Distribution of carnitine within the body and intracellular homeostasis of carnitine are controlled by novel organic cation transporters (OCTNs) that belong to the solute carrier 22A family, localized on the apical membrane of cells (8, 9).”
BackgroundFrohlich, J. J., Seccombe, D. W., Hahn, P., Dodek, P., & Hynie, I. (1978) · Metabolism · doi:10.1016/0026-0495(78)90022-7 · Cited by 130
König, B., Koch, A. H., Spielmann, J., Hilgenfeld, C., Stangl, G. I., & Eder, K. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.10.027 · Cited by 128 · cited 1×
“The mRNA expression of genes was measured by real-time detection PCR using SYBR Green I and the Rotor Gene 2000 system (Corbett Research, Mortlake, Australia) as described (29).”
MethodSelf-citationGrube, M., Meyer zu Schwabedissen, H. E. U., Präger;, D., Haney, J., Möritz, K.-U., Meissner, K., Rosskopf, D., Eckel, L., Böhm, M., Jedlitschky, G., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.586107 · Cited by 119
Chao, P., Chao, C., Lin, F., & Huang, C.-J. (2001) · Journal of Nutrition · doi:10.1093/jn/131.12.3166 · Cited by 102
van Vlies, N., Ferdinandusse, S., Turkenburg, M., Wanders, R. J. A., & Vaz, F. M. (2007) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2007.07.001 · Cited by 98 · cited 2×
“(41), it was also shown that similar effects occur in rats during fasting.”
BackgroundKato, Y., Sugiura, M., Sugiura, T., Wakayama, T., Kubo, Y., Kobayashi, D., Sai, Y., Tamai, I., Iseki, S., & Tsuji, A. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.024158 · Cited by 96
Thermally Oxidized Dietary Fat Upregulates the Expression of Target Genes of PPARα in Rat Liver
Sülzle, A., Hirche, F., & Eder, K. (2004) · Journal of Nutrition · doi:10.1093/jn/134.6.1375 · Cited by 91
Self-citationLahjouji, K., Elimrani, I., Lafond, J., Leduc, L., Qureshi, I. A., & Mitchell, G. A. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00333.2003 · Cited by 84
Paradoxical Effects of Clofibrate on Liver and Muscle Metabolism in Rats
Paul, H. S., & Adibi, S. A. (1979) · Journal of Clinical Investigation · doi:10.1172/jci109476 · Cited by 80 · cited 2×
“The present study confirms results of recent studies (18, 19, 25, 35) in showing that treatment with PPARa agonists increases the carnitine concentration in the liver of rodents.”
BackgroundResultVernez, L., Wenk, M., & Krähenbühl, S. (2004) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1470 · Cited by 70 · cited 1×
“carnitine-d3 (Larodane Fine Chemicals, Malmö, Sweden) as an internal standard (31).”
BackgroundPPARα agonists up-regulate organic cation transporters in rat liver cells
Luci, S., Geißler, S., König, B., Koch, A. H., Stangl, G. I., Hirche, F., & Eder, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.099 · Cited by 64 · cited 4×
“The present study confirms results of recent studies (18, 19, 25, 35) in showing that treatment with PPARa agonists increases the carnitine concentration in the liver of rodents.”
BackgroundResultInfluentialSelf-citationHirano, T., Yasuda, S., Osaka, Y., Kobayashi, M., Itagaki, S., & Iseki, K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.07.002 · Cited by 60
Luci, S., König, B., Giemsa, B., Huber, S., Hause, G., Kluge, H., Stangl, G. I., & Eder, K. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507669256 · Cited by 50
Self-citationKönig, B., & Eder, K. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.08.011 · Cited by 46 · cited 1×
“The cDNA synthesis was carried out as described (28).”
MethodSelf-citationOCTN3: A Na+‐independent L ‐carnitine transporter in enterocytes basolateral membrane
Durán, J. M., Rubio, M. J. P., Calonge, M. L., & Ilundáin, A. A. (2004) · Journal of Cellular Physiology · doi:10.1002/jcp.20193 · Cited by 41 · cited 2×
“In contrast, OCTN3 is expressed exclusively in testes, kidney, and intestine (12, 17).”
BackgroundMetabolism and excretion of carnitine and acylcarnitines in the perfused rat kidney
Hokland, B. M., & Bremer, J. (1986) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(86)90140-0 · Cited by 38
van Vlies, N., Wanders, R. J. A., & Vaz, F. M. (2006) · Analytical Biochemistry · doi:10.1016/j.ab.2006.04.007 · Cited by 35 · cited 2×
“As muscle is not able to produce carnitine (7), the increased carnitine concentration in skeletal muscle may be primarily the result of an increased uptake of carnitine from the blood by OCTN2.”
BackgroundChao, P., Hsu, S., Lin, F., Li, Y., & Huang, C. (2004) · Lipids · doi:10.1007/s11745-004-1224-4 · Cited by 34
Koch, A., König, B., Luci, S., Stangl, G. I., & Eder, K. (2007) · British Journal of Nutrition · doi:10.1017/s000711450775691x · Cited by 31 · cited 3×
“The present study confirms results of recent studies (18, 19, 25, 35) in showing that treatment with PPARa agonists increases the carnitine concentration in the liver of rodents.”
BackgroundResultSelf-citationL-Carnitine: New Aspects of a Known Compound – A Brief Survey
Lohninger, A., Pittner, G., & Pittner, F. (2005) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-005-0339-2 · Cited by 28 · cited 1×
“Carnitine is derived from dietary sources and endogenous biosynthesis (4, 5).”
BackgroundAbsorbing competition for carnitine
Taylor, P. M. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0283f.x · Cited by 25 · cited 1×
“Intestinal OCTN2 and OCTN3 are involved in the absorption of carnitine from the diet (17, 40).”
BackgroundMechanism of increased hepatic concentration of carnitine by clofibrate
Paul, H. S., Gleditsch, C. E., & Adibi, S. A. (1986) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1986.251.3.e311 · Cited by 22 · cited 1×
“The present study confirms results of recent studies (18, 19, 25, 35) in showing that treatment with PPARa agonists increases the carnitine concentration in the liver of rodents.”
ResultRenal handling of carnitine in ill preterm and term neonates
Zamora, S. A., Benador, N. M., Lacourt, G., & Girardin, E. P. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70042-0 · Cited by 12
Research works printed but not linked: 2
- 10.1042/bj3610417 · DOI · Paper page
- 10.1124/mol.59.2.358 · doi:10.1124/mol.59.2.358 · Paper page
Cited by
Noland, R. C., Koves, T. R., Seiler, S. E., Lum, H., Lust, R. M., Ilkayeva, O., Stevens, R. D., Hegardt, F. G., & Muoio, D. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.032888 · Cited by 317
Ringseis, R., Keller, J., & Eder, K. (2012) · European Journal of Nutrition · doi:10.1007/s00394-011-0284-2 · Cited by 160
Self-citationMakowski, L., Noland, R. C., Koves, T. R., Xing, W., Ilkayeva, O. R., Muehlbauer, M. J., Stevens, R. D., & Muoio, D. M. (2009) · The FASEB Journal · doi:10.1096/fj.08-119420 · Cited by 113
Xiang, F., Zhang, Z., Xie, J., Xiong, S., Chen, Y., Liao, D., Xia, B., & Lin, L. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06341-5 · Cited by 127
“In addition, PPARα also plays a regulatory role in carnitine synthesis by upregulating the carnitine synthases TMLD, TMABA-DH and BBD. PPARα is also involved in carnitine transport and uptake processes, and treatment with its activator increases the transcript levels of OCTN2 and OCTN3 [195, 196].”
Organic Cation Transporters in Human Physiology, Pharmacology, and Toxicology
Samodelov, S. L., Kullak-Ublick, G. A., Gai, Z., & Visentin, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217890 · Cited by 104
Metadata
- Authors
- Koch, A., König, B., Stangl, G. I., & Eder, K.
- Affiliations
- Martin Luther University Halle-Wittenberg (DE)
- Venue
- Experimental Biology and Medicine
- Publisher
- Frontiers Media SA
- Published
- 2008-03
- Volume
- 233
- Issue
- 3
- Pages
- 356-365
- ISSN
- 0071-3384 (ISSN-L)
- 1535-3702
- 1535-3699
- OpenAlex
- W2038827786
- Cited by
- 61
- References
- 45
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2022: 3 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 2 · 2015: 4 · 2014: 3 · 2013: 5 · 2012: 10
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Experimental Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- PPARα, organic cation transporters, OCTN2, carnitine synthesis, carnitine homeostasis, Wy-14,643, transcriptional regulation, carnitine transporter, PPARα knockout mice
- MeSH terms
- Solute Carrier Family 22 Member 5, Animals, Betaine, Body Weight, Carnitine, Liver, Lysine, Male, Membrane Proteins, Organ Specificity, Organ Size, RNA, Messenger, Transcription, Genetic, Up-Regulation, Mice, Knockout, Organic Cation Transport Proteins, PPAR alpha, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.